Executive Summary Act III of COVID: Navigating the Crosscurrents of Post-Inflation 2022 ushered in Act III of the market’s latest transitionary period: The Post-Inflation Era. Since 2008, the US economy functioned with remarkably low inflation and interest rates. As the cost of capital went lower and lower during the decade, valuations steadily rose. Between 2010 and 2020, the NASDAQ experienced a 17.1% annual growth rate, with no small share of the growth a result of expanding valuation
Read More
Q1 2022 Digital Health Funding Reaches $6B Across 183 Deals
What You Should Know: - Rock Health report reveals Q1 2022 digital health funding closed with $6.0B across 183 deals, and an average deal size of $32.8M. - Q1 2022 digital health funding was significantly behind Q4 2021’s $7.3B and the trailing twelve month quarterly average of $7.1B. Digital health funding reached a total of $6B in Q1 2022 across 183 deals, and an average deal size of $32.8M, according to Rock Health, a full-service venture fund
Read More
Healthcare SPAC Deep Medicine Acquisition Announces Pricing of $110M IPO
What You Should Know: - Deep Medicine Acquisition Corp. (the “Company”), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses announced today that it priced its upsized initial public offering of 11,000,000 units at $10.00 per unit. - The units are expected to be listed on The Nasdaq Global Market (“Nasdaq”) and trade under the ticker
Read More
Pear Therapeutics Goes Public Via $1.6B SPAC Deal – Digital Health IPO
What You Should Know: - Pear Therapeutics, the leader in developing and commercializing prescription digital therapeutics to treat serious disease, and Thimble Point Acquisition Corp (Nasdaq: THMA), a special purpose acquisition company (SPAC) whose management team is associated with the Pritzker Vlock Family Office, today announced that they have entered into a definitive business combination agreement. - Pursuant to the Business Combination Agreement, upon closing of the
Read More
Valo Health and Khosla Ventures Merge to Go Public in $2.8B SPAC Deal
What You Should Know: Valo Health, the technology company using human-centric data and artificial intelligence (AI) powered computation to transform the drug discovery and development process, and Khosla Ventures Acquisition Co. ("KVAC") (NASDAQ: KVSA), a special purpose acquisition (SPAC), announced today that they have entered into a definitive merger agreement. - The SPAC deal represents a pro forma market value of approximately $2.8B for the combined company. The combined company is
Read More
Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity
The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response. Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated. Over the course of the quarter, we observed $7 billion in private equity and venture capital investment across 158 companies. By comparison, Q1 of 2020 saw $3.2 billion and 127 investments. Health IT
Read More
Owlet Smart Baby Monitor to Go Public in SPAC IPO Deal
What You Should Know: - Owlet Baby Care Inc. (“Owlet” or the “Company”) and Sandbridge Acquisition Corporation, a special purpose acquisition company (SPAC) co-sponsored by affiliates of Sandbridge Capital and PIMCO private funds have entered into a definitive merger agreement go public. The company plans to be traded on the New York Stock Exchange (NYSE) under the symbol “OWLT.” - The combined company to have an implied initial enterprise value of approximately $1,074 million, with the
Read More
Sharecare to Go Public in SPAC IPO Deal, Reaching $3.9B Valuation
What You Should Know: - Digital health company Sharecare and special purpose acquisition company (SPAC), Falcon Capital Acquisition Corp, today announced an agreement to merge to go public on the NASDAQ under the ticker symbol SHCR at enterprise value of $3.9B. - The transaction is expected to be funded through a combination of Falcon's $345 million of cash in trust (assuming no redemptions) supported by a $425 million fully committed PIPE at $10.00 per share and the Anthem
Read More
SPAC Compute Health Acquisition Prices $750M IPO, Led by Intel Chairman
What You Should Know: - Compute Health Acquisition, a SPAC company targeting the intersection of computation and healthcare announced the pricing of its $750M initial public offering (IPO) by offering 75 million units at $10. Compute Health Acquisition Corp. (the “Company”), a SPAC “blank check” company announced today that it priced its initial public offering of 75,000,000 units at $10.00 per unit. The units will be listed on The New York Stock Exchange (“NYSE”) and trade under the
Read More
